Your browser doesn't support javascript.
loading
High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa.
Krogstad Mudzingwa, Emily; de Vos, Lindsey; Atujuna, Millicent; Fynn, Lauren; Mugore, Matinatsa; Mabandla, Selly; Hosek, Sybil; Celum, Connie; Bekker, Linda-Gail; Daniels, Joseph; Medina-Marino, Andrew.
Afiliação
  • Krogstad Mudzingwa E; The Desmond Tutu HIV Centre, University of Cape Town, Desmond Tutu Health Foundation, 3 Woodlands Road, Woodstock, Cape Town, 7915, South Africa.
  • de Vos L; Institute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT, USA.
  • Atujuna M; Research Unit, Foundation for Professional Development, Buffalo City Metro, Eastern Cape Province, South Africa.
  • Fynn L; The Desmond Tutu HIV Centre, University of Cape Town, Desmond Tutu Health Foundation, 3 Woodlands Road, Woodstock, Cape Town, 7915, South Africa.
  • Mugore M; The Desmond Tutu HIV Centre, University of Cape Town, Desmond Tutu Health Foundation, 3 Woodlands Road, Woodstock, Cape Town, 7915, South Africa.
  • Mabandla S; Mailman School of Public Health, Columbia University, New York, NY, USA.
  • Hosek S; HIV/AIDS, STIs and TB Directorate, Buffalo City Health District, Eastern Cape Provincial Department of Health, Bisho, South Africa.
  • Celum C; Department of Psychiatry, Stroger Hospital of Cook County, Chicago, IL, USA.
  • Bekker LG; Division of Infectious Diseases, Stroger Hospital of Cook County, Chicago, IL, USA.
  • Daniels J; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Medina-Marino A; Department of Epidemiology, University of Washington, Seattle, WA, USA.
J Behav Med ; 47(2): 320-333, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38081955
In Southern and Eastern Africa, initiation of daily oral pre-exposure prophylaxis (PrEP) for HIV prevention has been high among adolescent girls and young women (AGYW) offered PrEP. However, persistence and prevention-effective use of PrEP among this critical group continues to be a challenge. We conducted a qualitative sub-study of AGYW from the Community PrEP Study in Eastern Cape Province, South Africa who had high rates of pick up for monthly PrEP refills over two years, but differing levels of PrEP adherence based on tenofovir-diphosphate (TFV-DP) measurements in dried blood spots (DBS). Contrasting 22 AGYW with low versus high levels of TFV-DP in DBS, we qualitatively explored factors which influenced PrEP persistence vs. non-persistence, unique patterns of PrEP use (e.g., discarding or stockpiling), and participant recommendations for improving AGYW prevention-effective use of PrEP in the future. Results showed that PrEP misconceptions and mistrust among participants' social networks negatively influenced adherence. In comparison, supportive families and/or partners and personal trust that PrEP works positively influenced adherence. Those with low adherence described being motivated to come to the site for other study benefits (e.g., reimbursement money, snacks, sanitary pads) and discarding PrEP to avoid stigma associated with being seen with pills. Future PrEP implementation strategies should focus on involving families and partners in PrEP support for AGYW and minimizing PrEP stigma at a community level.Trial registration NCT03977181. Retrospectively registered on June 6, 2019.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Organofosfatos / Adenina / Infecções por HIV / Fármacos Anti-HIV Limite: Adolescent / Female / Humans País como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Organofosfatos / Adenina / Infecções por HIV / Fármacos Anti-HIV Limite: Adolescent / Female / Humans País como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article